Regeneron Pharmaceuticals Inc (REGN)

About Regeneron Pharmaceuticals, Inc. (REGN)

Company Description:


Regeneron Pharmaceuticals, Inc. specializes in the discovery, development, and commercialization of treatments for serious medical conditions. The company's primary focus is on biotechnology, developing medicines for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases.

Founded in 1988 by Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos, Regeneron is headquartered in Tarrytown, New York, USA.


Main Product(s):


Regeneron is known for its innovative medicines, including treatments for eye diseases, high LDL cholesterol, atopic dermatitis, asthma, and rheumatoid arthritis. It is also known for its VelociSuite technologies, which are used in drug discovery and development.


Short History of Regeneron Pharmaceuticals, Inc:


  • 1988 – Founded by Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos.
  • 1991 – Became a public company.
  • 2008 – FDA approval of EYLEA, a treatment for neovascular age-related macular degeneration.
  • 2015 – Approval of Praluent for lowering LDL cholesterol.
  • 2020 – Development of REGN-COV2 (later named REGEN-COV), a cocktail of monoclonal antibodies for COVID-19.

Key Executives:

NameTitlePayExercisedYear Born
Dr. Leonard S. Schleifer M.D., Ph.D.Co-Founder, President, CEO & Co-Chairman7MN/A1953
Dr. George D. Yancopoulos M.D., Ph.D.Co-Founder, President, Chief Scientific Officer & Co-Chairman6.59MN/A1960
Mr. Robert E. Landry Jr.Executive VP of Finance & CFO1.84M11.1M1964
Dr. Andrew J. Murphy Ph.D.Executive Vice President of Research1.62M19.39M1959
Mr. Daniel P. Van PlewExecutive VP and GM of Industrial Operations & Product Supply1.95M45.28M1973
Ms. Marion E. McCourtExecutive Vice President of Commercial1.5M4.25M1960
Ms. Patrice GiloolySenior Vice President of Quality Assurance & OperationsN/AN/AN/A
Mr. Christopher R. Fenimore CPASenior VP, Head of Accounting & ControllerN/AN/A1971
Mr. Gerald UnderwoodSenior Vice President of Technical OperationsN/AN/AN/A
Mr. Bob McCowanSenior VP of IT & Chief Information OfficerN/AN/AN/A

Trade smart with Robert Lindner

Charts and financial information provided by TradingView, a popular charting & trading platform.

Check out even more advanced features or grab charts for your website.